Share this:
  Issue 23  •  November 2023                                                                                     PMI Grants Team

Continuing Resolution and NIAID Financial Management Plan
NIH is operating under a continuing resolution through November 17, 2023.  As a result, NIAID has made adjustments to funding levels for grants, selective pay, and bridge pools.
Competing investigator-initiated awards will be funded at 90 percent of approved funding level with start dates reset by one month. This excludes fellowship (F), training (T), career development (K), and small business (SBIR/STTR) awards, and awards funded with non-direct appropriations (e.g., emergency supplemental COVID appropriations), which will be funded with no reduction to the approved funding level.
For a competing R01 renewal grant, NIAID will fund at 90 percent of approved funding level after applying the renewal budget cap.
Noncompeting (Type 5, Type 8) continuation awards will be funded at 90 percent of the FY 2024 committed level. This excludes Fs, Ts, Ks, SBIRs/STTRs, and awards funded with non-direct appropriations (e.g., emergency supplemental COVID appropriations).
Extensions (Type 4) will be funded at 90 percent of the anticipated FY 2024 level. This excludes Ks (R00) and SBIR/STTRs, which will be funded with no reduction to the anticipated FY 2024 level.
More details available here: NIAID, NOT-OD-24-007

NIH's Data Management (DMS) & Sharing Plan 
The NIH Data Management & Sharing DMS Policy applies to all research, funded or conducted in whole or in part by NIH, that results in the generation of scientific data.
Under the DMS policy, NIH expects that investigators and institutions:
  • Plan and budget for the managing and sharing of data
  • Submit a DMS plan for review when applying for funding
  • Comply with the approved DMS plan
Additional information is available via the following links:

NIAID Sample Applications & More
Several NIAID investigators have graciously agreed to share their exceptional applications and summary statements as samples to help the research community. Click here for details.

Missing PMCIDs and other common errors on proposals 
The PMI grants team encourages applicants to review these items often overlooked for compliance on NIH proposals.

Just-In-Time (JIT)
When do you need to submit a JIT for NIH and how does it work? Click here for detailed information about NIH's Just-in-Time mechanism and PMI JIT policy. 
Here are a few links for various institutes' current paylines: NIAID, NIDDK, NCI, NHLBI.

Planning a proposal submission in the next 2-3 months?

In an effort to better serve you, the PMI grants team requests that PIs and Fellows notify us as far in advance as possible of submission plans.  This ensures ample time to complete departmental requirements and also route to OSP for review by their deadline.   

Funding Opportunities by Agency
American Cancer Society
Discovery Boost Grants (DBG) high-risk, high-reward exploratory cancer research.  Awards are for up to 2 years with $125,000 a year for direct costs, plus 20% allowable indirect costs.  Final submission via proposal Central: 04/01/24.
Mission Boost Grants (MBG)  Stage I Mission Boost: $100,000/year for two years direct costs, plus 20% indirect costs.  Stage II Mission Boost:  Applicants may propose up to 18 months and $500,000 for direct costs, plus 20% indirect costs.  Final submission via proposal Central: 04/01/24.
Research Scholar Grants  Awards are for up to 4 years with up to $200,000 a year for direct costs, plus 20% allowable indirect costs.  Final submission via proposal Central: 04/01/24.
Postdoctoral Fellowship  $66,000 Yr 1, $68,000 Yr 2,  $70,0000 Yr 3, and additional $4,000/year Fellowship allowance. Final submission via proposal Central: 04/01/24.
Clinician Scientist Development Grant (CSDG)  Awards may be for 3 to 5 years with $135,000 a year for direct costs, plus 8% allowable indirect costs. Final submission via proposal Central: 04/01/24.

American Heart Association
AHA 2024 Tranformational Project Award $100,000/year for three years, including 10% indirects. Full application: 02/15/24.
2024 Innovative Project Award $100,000/year including 10% indrects for two years.  Pre-proposal due 12/01/23.  Full application by invitation: 03/08/24.
Damon Runyon Cancer Research Foundation
Damon Runyon Clinical Investigator Award  $200,000/yr for three years.  Applications must be submitted through proposal central by 02/01/24.
Damon Runyon Fellowship Award  fellowships provide a stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000 Yr 3, and $76,000 Yr 4, plus 2K/year research allowance. Applications must be submitted through proposal central by 03/15/24.                                                                                                                                    

Patient-Centered Outcomes Research Institute (PCORI)

Broad Pragmatic Studies PFA: Category 1, Category 2, and Category 3 Study Specifications
  • Category 1 will support research projects with direct costs up to and  including $5 million.
  • Category 2 will support research projects with direct costs greater than $5 million and up to a maximum of $10 million. 
  • Category 3 will support research projects with direct costs up to $10 million that utilize PCORnet® to conduct observational studies and/or pragmatic trials that are national in scale. 
This PCORI Funding Announcement, under Cycle 1 2024, will open on January 9, 2024.
     NIH Deadlines 
January
AIDS AND AIDS-Related Applications. (New, Renewal, Resubmission, Revision) Routing: 12/26/23, Sponsor: 01/07/24
P Series (New, Renewal, Resubmission, Revision) Routing: 01/15/24, Sponsor: 01/25/24 

R18, U18, R25 (New, Renewal, Resubmission, Revision) Routing: 01/15/24, Sponsor: 01/25/24

T & D Series (New, Renewal, Resubmission, Revision)  Routing: 01/15/24, Sponsor: 01/25/24
February
R01 (New)  Routing: 01/24/24, Sponsor: 02/05/24
U01 (New) Routing: 01/24/24, Sponsor: 02/05/24
K Series (New) Routing: 01/31/24, Sponsor: 02/12/24 
R21 (New) Routing: 02/06/24, Sponsor: 02/16/24 
March 
R01 (Renewal, resubmission, revision) Routing: 02/22/24, Sponsor: 03/05/24
U01 (Renewal, resubmission, revision) Routing: 02/22/24, Sponsor: 03/05/24
K Series (New) Routing: 02/29/24, Sponsor: 03/12/24 
R21 (New) Routing: 03/06/24, Sponsor: 03/16/24
April 
F series (New, Renewal, Resubmission)  Routing: 03/27/24, Sponsor: 04/08/24
R13, U13 (New, Renewal, Resubmission, Revision) Routing: 04/02/24, Sponsor: 04/12/24
May 
AIDS AND AIDS-Related Applications. (New, 
Renewal, Resubmission, Revision) Routing: 04/25/24, Sponsor: 05/07/24
P Series (New, Renewal, Resubmission, Revision) Routing: 05/14/24, Sponsor: 05/25/24 
 
R18, U18, R25 (New, Renewal, Resubmission, Revision) Routing: 05/14/24, Sponsor: 05/25/24

T & D Series (New, Renewal, Resubmission, Revision)  Routing: 05/14/24, Sponsor: 05/25/24
June
R01 (New)  Routing: 05/24/24, Sponsor: 06/05/24
U01 (New) Routing: 05/24/24, Sponsor: 06/05/24
K Series (New) Routing: 05/31/24, Sponsor: 06/12/24 
R21 (New) Routing: 06/04/24, Sponsor: 06/16/24 
Additional Funding Opportunities:
Alex's Lemonade Stand Foundation Crazy 8 Initiative Program on Childhood Cancer Predisposition   $3-5 million  over four years.  LOI: 01/04/24, full application by invitation due: 04/17/24.
RFA-AI-23-059 Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) Up to 350K directs/year. Optional LOI due 30 days prior to application due date.  Sponsor deadline: 01/26/2024.
PAR-22-225 NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)  Application budgets are not limited but need to reflect the actual needs of the proposed project.  Next deadlines: 01/11/24 and 06/11/24.  AIDS application due dates: 05/07/24 and 09/07/24.
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards Up to 70K.  Deadlines vary by awarding IC.
Request for Nominations 2024 LUPUS INSIGHT PRIZE $100,000  Lupus Research Alliance.  Nominations due: 01/16/24.
Jane Coffin Childs Memorial Fund for Medical Research 3 year fellowship: 70K Yr1, 72K Yr 2, and 74K Yr 3.  Proposals due: 02/01/24.
PAR-23-145 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)   up to $250,000 direct costs/year.  Next due dates: 02/01/24 and 10/03/24.
PAR-23-275 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)  Application budgets are not limited but need to reflect the actual needs of the proposed project.  Next due dates: 02/05/24 and 06/05/24.  Next AIDS deadlines: 01/07/24 and 05/07/24.
PAR-23-149 Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)  Next due dates: 02/12/24 and and 06/12/24.
VUMC Faculty Research Scholars $110,000/year, SOI: 01/15, full application 02/15/24.
PAR-23-056 Co-infection and Cancer (R21 Clinical Trial Not Allowed) Next due dates: 02/16/24 and 06/16/24.
PAR-21-271 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) standard due dates.
PAR-23-055 Co-infection and Cancer (R01 Clinical Trial Not Allowed)   Application budgets are not limited but need to reflect the actual needs of the proposed project.  Earliest submission dates for new applications: 02/05/24 and 06/05/24.
RFA-AI-23-057 Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Due: 03/13/24.
PAR-23-024 Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)  Direct costs are limited to $350,000 per year.  Due 05/01/24.
PAR-23-246 Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)  Up to  $475K in direct costs/year.  Due: 05/03/24.
PAR-23-098 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)  Up to $1.5 million direct costs/year.  LOI: 05/10/2024, full application: 06/21/2024.
PAR-23-139 CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)  direct costs for the two-year project period may not exceed $275,000.  Due: 05/30/2024.
PAR-22-080 Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Maximum award is $600,000.  Due: 06/03/24.
PAR-22-079 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)  Awards range from $750,001 - $2,000,000   Due: 06/03/24.

Have a pressing inquiry regarding submissions or post-award items? 

We're here to help!  Candice Stevens, Associate Director, Lauren Milam, Administrative Manager, Karin Sack, Grants Manager, Leigh Thompson, Budget Accounting Analyst Post-Award, and Alethea Kelly, Budget Accounting Analyst Pre-Award.
Questions, concerns on Grants-At-A-Glance, or prefer unsubscribe? 
Contact Karin Sack, and/or Alethea Kelly.
Grants-At-A-Glance Archive
Vanderbilt University Medical Center 1161 21st Ave S | Nashville, TN 37232 US
powered by emma
Subscribe to our email list.